Analysts at Roth Capital initiated coverage on Spark Therapeutics, Inc. ONCE with a Buy rating. The target price for Spark Therapeutics is set to $71. Spark Therapeutics' shares closed at $46.00 yesterday.
Analysts at Pacific Crest initiated coverage on Proto Labs, Inc. PRLB with a Sector Perform rating. Proto Labs' shares closed at $71.07 yesterday.
Barrington Research initiated coverage on HealthEquity, Inc. HQY with a Outperform rating. The target price for HealthEquity is set to $25. HealthEquity shares closed at $20.13 yesterday.
Analysts at Chardan Capital initiated coverage on Avalanche Biotechnologies, Inc. AAVL with a Neutral rating. The target price for Avalanche Biotechnologies is set to $40. Avalanche Biotechnologies' shares closed at $39.74 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in